724
Participants
Start Date
June 3, 2009
Primary Completion Date
December 4, 2014
Study Completion Date
December 4, 2014
Everolimus
Everolimus was formulated as tablets of 5-mg strength and was packaged into blister packs . Everolimus (two 5 mg tablets daily) were administered in a blinded manner on their respective treatment arms by continuous oral daily dosing.
Exemestane
Exemestane 25 mg orally daily.
Everolimus Placebo
Placebo was formulated to be indistinguishable from the everolimus tablets. Matching placebo (two tablets daily) were administered in a blinded manner on their respective treatment arms by continuous oral daily dosing.
Novartis Investigative Site, Brussels
Novartis Investigative Site, Brussels
Novartis Investigative Site, Wilrijk
Novartis Investigative Site, Leuven
Novartis Investigative Site, Parkville
Novartis Investigative Site, Parkville
Novartis Investigative Site, Liège
Novartis Investigative Site, Redcliffe
Novartis Investigative Site, Nambour
Novartis Investigative Site, Salzburg
Novartis Investigative Site, Bedford Park
Novartis Investigative Site, Subiaco
Novartis Investigative Site, Christchurch
Novartis Investigative Site, Sint-Niklaas
Beth Israel Medical Center Dept.ofBeth Israel Med. Ctr(2), New York
Weill Cornell Medical College Weill Cornell Med. Ctr., New York
Novartis Investigative Site, Berlin
Novartis Investigative Site, Torino
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Hematology Oncology Association of Rockland, Nyack
Clinical Research Alliance Dept.ofArenaOncologyAssoc(2), Lake Success
ProHealth Care, Lake Success
Novartis Investigative Site, Marseille
Novartis Investigative Site, Prague
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Genova
Medical Oncology & Hematology Associates of Northern VA Med. Onc&Hem Assoc. of No.VA, Reston
Holy Cross Hospital Holy Cross, Silver Spring
Novartis Investigative Site, Saronno
Novartis Investigative Site, Varese
Mercy Medical Center Medical Oncology & Hematology, Baltimore
Maryland Hematology/Oncology Associates, P.A., Baltimore
Anne Arundel Health System Research Institute Wayson Pavilion, Annapolis
Frederick Memorial Hospital Dept. of FMH-IRB, Frederick
Novartis Investigative Site, Lleida
Marion L. Shepard Cancer Center, Washington
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Málaga
Medical University of South Carolina -Hollings Cancer Center Dept. MUSC/HollingsCancerCtr, Charleston
Georgia Cancer Specialists. Drug Ship, Decatur
MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2), Orlando
Memorial Hospital Memorial Cancer Institute, Hollywood
Comprehensive Cancer Center - Boca Raton Deerfield Beach, Boca Raton
Florida Cancer Research Institute, Davie
Palm Beach Cancer Institute, West Palm Beach
Florida Medical Clinic PA Dept.ofFloridaMedicalClinic, Zephyrhills
Florida Cancer Specialists DeptofFloridaCancerSpecialists, Fort Myers
Novartis Investigative Site, Altunizade
Novartis Investigative Site, Izmir
Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(5), Nashville
University of Louisville / James Graham Brown Cancer Center SC, Louisville
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Seville
Novartis Investigative Site, Saint-Nazaire
Novartis Investigative Site, Saint-Herblain Cédex
Hematology Oncology of Indiana, Indianapolis
Horizon Oncology Center, Lafayette
Novartis Investigative Site, Münster
Novartis Investigative Site, Antella - Bagno A Ripoli
Novartis Investigative Site, Chiang Mai
University of Wisconsin Hospital & Clinics UW ComprehensiveCancerCtr(2), Madison
Novartis Investigative Site, Trier
Fairview Southdale Medical Oncology Clinic, Edina
Novartis Investigative Site, Hwasun-gun
Novartis Investigative Site, Frankfurt
Rush University Medical Center Study Coordinator, Chicago
Novartis Investigative Site, Macerata
St. Louis Cancer & Breast Institute Dept.ofSt.LouisCancer&Breast, St Louis
Novartis Investigative Site, Mannheim
Southeast Nebraska Oncology Cancer Center, Lincoln
Novartis Investigative Site, Lyon
Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2, Metairie
Hematology Oncology Clinic Hematology Oncology Clinic (2), Baton Rouge
Novartis Investigative Site, Le Mans
Novartis Investigative Site, Brindisi
Highlands Oncology Group DeptofHighlandsOncologyGrp(2), Fayetteville
Cancer Centers of Southwest Oklahoma Cancer Research Dept.of Southwest Oklahoma, Lawton
Cancer Care Associates SC, Tulsa
Novartis Investigative Site, Paris
Hope Oncology HOPE Richardson, Richardson
Novartis Investigative Site, Rouen
Novartis Investigative Site, Rouen
The Center for Cancer and Blood Disorders Dept. of The Ctr for C & BD(2), Fort Worth
Novartis Investigative Site, München
Novartis Investigative Site, München
Utah Cancer Specialists Dept.of Utah Cancer Spec. (2), Salt Lake City
University of Utah / Huntsman Cancer Institute Dept.ofHuntsmanCancerInst.(2), Salt Lake City
Central Utah Clinic CRAD001Y2301, Provo
Ironwood Cancer and Research Centers, Chandler
Novartis Investigative Site, La Roche-sur-Yon
University of New Mexico Cancer Research Center Dept of UNM Cancer & Research, Albuquerque
The Angeles Clinic and Research Institute, Los Angeles
USC/Kenneth Norris Comprehensive Cancer Center Regulatory Contact 3, Los Angeles
Novartis Investigative Site, Songkhla
Premiere Oncology/Pinnacle Oncology Hematology Dept.ofPremiereOncologyAZ, Santa Monica
Scripps Clinic SC, La Jolla
Sharp Memorial Hospital SharpClinicalOncologyResearch, San Diego
Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C, Anaheim
Comprehensive Blood and Cancer Center Dept. of CBCC (3), Bakersfield
Cancer Care Associates Dept.ofCancerCareAssoc. (2), Fresno
University of California San Francisco UCSF Medical Center, San Francisco
St Joseph Heritage Healthcare Dept. of RRMG (4), Santa Rosa
Novartis Investigative Site, Catania
Grass Valley Hematology Oncology Medical Group Dept. of Grass Valley Hem/Onc, Grass Valley
Oncology Specialists, SC Dept.of Oncology Specialists, Park Ridge
Cancer Center of Kansas Dept.ofCancerCtr.ofKansas, Wichita
Weinberg Cancer Institute at Franklin Square Hospital, Baltimore
Lahey Clinic Dept of Lahey Clinic (2), Burlington
Regional Cancer Care Associates Dept. of the CCHD, Cherry Hill
Trinitas Comprehensive Cancer Center Dept. of Trinitas, Elizabeth
Penn State University / Milton S. Hershey Medical Center Division of Oncology (2), Hershey
University of Texas Southwestern Medical Center SimmonsComprehensiveCancerCtr., Dallas
University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(2), Houston
Northern Utah Cancer Associates SC, Ogden
Novartis Investigative Site, Innsbruck
Novartis Investigative Site, Wels
Novartis Investigative Site, Linz
Novartis Investigative Site, Vienna
Novartis Investigative Site, Salvador
Novartis Investigative Site, Uberlândia
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Calgary
Novartis Investigative Site, Moncton
Novartis Investigative Site, Halifax
Novartis Investigative Site, Cambridge
Novartis Investigative Site, London
Novartis Investigative Site, Newmarket
Novartis Investigative Site, St. Catharines
Novartis Investigative Site, Toronto
Novartis Investigative Site, Toronto
Novartis Investigative Site, Weston
Novartis Investigative Site, Greenfield Park
Novartis Investigative Site, Montreal
Novartis Investigative Site, Montreal
Novartis Investigative Site, Montreal
Novartis Investigative Site, Québec
Novartis Investigative Site, Sherbrooke
Novartis Investigative Site, Brno
Novartis Investigative Site, Olomouc
Novartis Investigative Site, Menoufiya
Novartis Investigative Site, Alexandria
Novartis Investigative Site, Cairo
Novartis Investigative Site, Hong Kong SAR
Novartis Investigative Site, Budapest
Novartis Investigative Site, Szeged
Novartis Investigative Site, Szolnok
Novartis Investigative Site, Perugia
Novartis Investigative Site, Terni
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Kashiwa
Novartis Investigative Site, Matsuyama
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Kitakyushu
Novartis Investigative Site, Maebashi
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Kagoshima
Novartis Investigative Site, Isehara
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Kyoto
Novartis Investigative Site, Osaka
Novartis Investigative Site, Osaka
Novartis Investigative Site, Suita
Novartis Investigative Site, Hidaka
Novartis Investigative Site, Kitaadachi-gun
Novartis Investigative Site, Bunkyo-ku
Novartis Investigative Site, Chuo-ku
Novartis Investigative Site, Chuo-ku
Novartis Investigative Site, Koto
Novartis Investigative Site, Eindhoven
Novartis Investigative Site, Alkmaar
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Dordrecht
Novartis Investigative Site, Sittard-Geleen
Novartis Investigative Site, The Hague
Novartis Investigative Site, Lørenskog
Novartis Investigative Site, Krakow
Novartis Investigative Site, Rzeszów
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Mallorca
Novartis Investigative Site, Palma de Mallorca
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Terrassa
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Ankara
Novartis Investigative Site, Broomfield
Novartis Investigative Site, Truro
Novartis Investigative Site, Cardiff
Novartis Investigative Site, Nottingham
Novartis Investigative Site, Sheffield
Novartis Investigative Site, Southampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY